News archive
On this page you can search for older news. Choose a topic, type of news or enter your own keyword to filter out news.
View compact

Researchers from Karolinska Institutet and Sachs’ Children and Youth Hospital have mapped the immune system in the gut of children with inflammatory bowel disease (IBD). The results, which were published in Cell Reports Medicine, can be used to design more targeted therapies.
News

13 January, 2023
Uric acid linked to later risk for irregular heart rhythmHigh levels of uric acid in midlife may significantly raise the risk for a serious type of irregular heartbeat in the decades that follow, even in people without traditional risk factors, new research from Karolinska Institutet published in the Journal of the American Heart Association shows.
News

17 August, 2022
Improved reliability of epigenetic clocksEpigenetic clocks based on DNA methylation data are widely used aging biomarkers useful to assess biological age in population-based cohorts. However, their utility has been limited by technical noise. In this paper, we present a method that produces high-reliability clocks for applications such as longitudinal studies and intervention trials.
News

Researchers at Karolinska Institutet have compared how well different Alzheimer’s biomarkers predict the progression of the disease and its effect on the memory. They found that early accumulation of tau proteins in the brain as measured by PET scanner was more effective at predicting memory impairment than biomarkers in the cerebrospinal fluid or amyloid plaque in the brain. The results are published in the journal Molecular Psychiatry.
News

Rapid diagnosis is crucial in bacterial soft tissue infections to reduce the risk of severe injury or amputation. Vague symptoms and a heterogeneous patient group increase the risk of misdiagnosis. Researchers at Karolinska Institutet and other research institutions have now, with the help of AI, identified a new and very promising biomarker. The study, published in the Journal of Clinical Investigation, may have implications for both diagnosis and treatment.
News

A study involving researchers at Karolinska Institutet and University of Gothenburg has found that low levels of a protein called PDGFRb are associated with particularly good results of radiotherapy in women with early-stage breast cancer. The study, which is published in the journal Clinical Cancer Research, also suggests that the efficacy of radiotherapy can be improved with drugs that block this protein.
News

The causes of the serious muscle disease ALS still remain unknown. Now, researchers at Karolinska Institutet and KTH Royal Institute of Technology, among others, have examined a type of cell in the brain blood vessels that could explain the unpredictable disease origins and dynamics. The results indicate a hitherto unknown connection between the nervous and vascular systems. The study, published in Nature Medicine, has potential implications for earlier diagnoses and future treatments.
News

Good cholesterol, which is transported in HDLs (high-density lipoproteins), plays a key part in the prevention of atherosclerosis and thus the risk of cardiovascular disease. However, according to a new paper co-authored by researchers at Karolinska Institutet and published in the journal Circulation, the anti-inflammatory properties of HDLs could be an even better biomarker for future cardiovascular events.
News

11 December, 2020
Genetic differences important for Alzheimer's diagnosisThe two used methods for detecting amyloid pathology in Alzheimer's disease give ambiguous results, with the risk of incorrect or delayed care interventions. Now, researchers at Karolinska Institutet have found genetic explanations for the differences. The study is published in Molecular Psychiatry and may be important for more individual diagnostics and the development of future drugs.
News

10 November, 2020
Mid-levels of immune marker at birth may protect against autismResearchers at Karolinska Institutet have investigated the association between certain immune markers in neonates and the risk of later developing autism spectrum disorder (ASD). They found that mid-levels of a classical marker of inflammation, C-reactive protein, were associated with the lowest risk for ASD – whereas too much or not enough were linked to increased risk. The study is published in the scientific journal Biological Psychiatry.
News

1 July, 2020
Blood tests can predict the risk of liver cirrhosisRepeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet published in the Journal of Hepatology. The risk of liver cirrhosis increases if the levels of this biomarker rise between two testing occasions.
News
Victor Bloniecki Kallio, PhD-student at the Division of Clinical Geriatrics. On May 27, 2020, you will defend your thesis "Using CSF biomarkers to understand mechanisms of behavioral changes and effects of drug treatment in dementia", what's the main focus of the thesis?
News

11 February, 2020
New measure of biological age can predict health risksPeople age in different ways. Biological age is a metric that scientists use to predict health risks, the relevance of which can be enhanced by combining different markers. Particularly important markers are frailty and the epigenetic clock, write researchers from Karolinska Institutet in a study published in eLife.
News

21 October, 2019
New biomarkers for childhood asthma may facilitate early diagnosisResearchers at Karolinska Institutet have followed children who have sought emergency care for wheezing during their first years of life and found specific biomarkers that can predict the need for asthma medication several years later. The study is published in the prestigious European Respiratory Journal.
News

Researchers at Karolinska Institutet in Sweden have identified blood-based biomarkers that may determine which patients will benefit from continued hormonal therapy for advanced prostate cancer. The results are published in the journal JAMA Oncology. The researchers envision that this discovery may eventually result in a test that contributes to a more personalised treatment of the disease.
News


12 January, 2018
Genetic analysis can improve depression therapyThe failure of drugs such as SSRIs, used to treat depression, can be a result of genetic variations in patients. Variations within the gene that encodes the CYP2C19 enzyme results in extreme differences in the levels of escitalopram achieved in patients, according to a new study published in The American Journal of Psychiatry. Prescribing the dose of escitalopram based on a patient’s specific genetic constitution would greatly improve therapeutic outcomes.
News

News

News

News


